查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968474

约翰氏症诊断市场－全球产业规模、份额、趋势、机会、预测：按动物类型、检测类型、最终用户、地区和竞争对手划分，2021-2031年

Johne's Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Test Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球约翰尼氏症诊断市场预计将从 2025 年的 6.7566 亿美元成长到 2031 年的 9.8755 亿美元，复合年增长率为 6.53%。

此领域包括专门用于识别牲畜群体中副结核分枝桿菌的检测平台和分析方法，例如聚合酵素链锁反应(PCR) 和酵素免疫分析法试验 (ELISA)。推动这一领域发展的主要因素是迫切需要解决生产损失问题，特别是因感染牛早期淘汰和产奶量下降造成的损失。此外，严格的贸易通讯协定和牛健康认证计画要求频繁监测，迫使生产者维持定期筛检计画。例如，爱尔兰动物健康协会 (Animal Health Ireland) 在 2024 年报告称，该疾病每年给爱尔兰酪农行业造成 1124 万至 2385 万欧元的损失，凸显了有效诊断解决方案的必要性，这也凸显了经济风险。

市场概览
预测期 2027-2031
市场规模：2025年 6.7566亿美元
市场规模：2031年 9.8755亿美元
复合年增长率：2026-2031年 6.53%
成长最快的细分市场 酵素连结免疫吸附试验
最大的市场 北美洲

市场扩张的主要障碍在于现有诊断方法在疾病漫长的无症状期敏感度不足。受感染动物通常产生的抗体水平极低，或多年持续排放少量细菌，导致假阴性结果频繁，阻碍根除工作。这项早期感染检测的技术难题会削弱生产者对筛检的信心，从而减缓注重成本的畜牧场采用综合检测系统的步伐。

市场驱动因素

快速血清学和分子诊断技术的创新正在从根本上改变市场格局，满足了对检测副结核分枝桿菌（Mycobacterium avium subspecies paratuberculosis）的灵敏度和速度的迫切需求。高通量PCR和噬菌体技术的进步显着加快了活菌的鑑定速度，相较于以往耗时数月的培养方法，速度大幅提升。例如，2024年11月出版的《日誌 ）刊登了报导题为“一种检测1日龄牛约翰尼氏病的新方法”的文章，报导了一种新型诊断系统，在75%的受试病例中，其检测性行为感染的时间比标准粪便PCR检测至少提前四周。这些进展对于切断感染链至关重要，使养殖户能够在牛污染环境、损害生产指标之前将其隔离。

此外，政府强制推行的疾病控制和根除计画是推动疾病防治的第二个主要因素，使得定期筛检成为标准作业要求。这些法规结构通常将市场进入与牛群健康挂钩，农民必须严格遵守检查计画才能维持贸易认证。正如发表在《预防兽医学》（2024年8月）上的文章「英国酪农牛约翰尼病疫情十年变化」所指出的，监测数据显示，平均检测值最高的25%的牛占所有阳性结果的42%，这凸显了集中式方案在管理高风险牛群方面的重要性。此外，这些计划还促进了综合管理。根据2024年《乳品科学杂誌》的报道，将牛纳入检查通讯协定可将疾病传播减少高达30%，这推动了全球对诊断试剂的需求。

市场挑战

全球约翰尼病诊断市场发展面临的主要障碍之一是现有检测工具在疾病漫长的无症状期灵敏度不足。受感染的牲畜往往携带副结核分枝桿菌多年，却不表现出足够的抗体反应或排放可检测的细菌量，导致标准检测经常出现假阴性结果。无法准确检测这些早期携带者会削弱生产者对监测措施成本效益的信心。由于传播源未被发现，即使投入大量筛检资金也无法阻止后续疫情的爆发，因此畜牧业主往往不愿投入资金进行能够带来市场收益的定期检测。

这种怀疑态度也因数据显示圈养牲畜群体中约翰氏症检出率较低而进一步加剧。根据约翰氏症行动小组的数据，2024年英国监测牛的牛奶ELISA检测平均阳性率为2.7%。虽然这一数字表明疫情控制有效，但也凸显了诊断在发现更广泛的无症状感染方面面临的挑战，这阻碍了注重成本的农业企业广泛实施主动筛检通讯协定。

市场趋势

人工智慧驱动的微型RNA生物标记技术的兴起，正透过克服传统血清学检测固有的灵敏度限制，彻底改变全球约翰氏症诊断市场。与依赖延迟抗体产生的ELISA检测不同， 微型RNA分析透过分析宿主反应基因表现，在无症状携带者出现传染性之前将其检测出来。这种利用机器学习演算法的分子策略，能够对标准检测方法无法辨识的早期感染阶段进行精准分类。根据2025年5月发表在DVM360上的报导《一种新的诊断方法有助于早期发现牛约翰氏症》，一种新近检验的人工智慧驱动的微型RNA模型在检测I期和II期感染方面达到了71.8%的准确率，为识别无症状携带者和阻断感染循环提供了重要工具。

同时，诊断检测与云端畜群管理平台的整合正推动畜牧业从被动诊断转向预测性风险分层。先进的软体解决方案整合历史检测数据，产生动态风险评分，使生产者不仅能够应对阳性结果，还能预测疾病进展。这种数位化支持演算法丛集，识别出可能被标准通讯协定忽略的高风险动物。根据2025年2月《农民周刊》发表的题为「新型数据分析工具提升约翰尼病风险检测」的报导，预测分析显示，特定高风险数据丛集中的动物感染约翰尼病的可能性比低风险组高出1000倍，这有助于实施预防性生物安全措施。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球约翰氏症诊断市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 动物种类（牛、山羊、绵羊）
    • 依检测方法（ELISA、PCR、AGID 等）
    • 依最终使用者（兽医院/诊所、其他）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美约翰氏症诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲约翰氏症诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区约翰氏症诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲约翰氏症诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲约翰氏症诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球约翰氏症诊断市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Zoetis Inc.
  • Thermo Fisher Scientific, Inc.
  • PBD Biotech Ltd
  • IDEXX Laboratories, Inc.
  • Innovative Diagnostics SAS
  • VMRD Inc.
  • BIOMeRIEUX SA
  • INDICAL BIOSCIENCE GmbH
  • Tetracore, Inc.
  • Surefarm Ltd

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19114

The Global Johne's Disease Diagnostics Market is projected to expand from USD 675.66 Million in 2025 to USD 987.55 Million by 2031, registering a CAGR of 6.53%. This sector encompasses testing platforms and analytical assays, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISA), specifically engineered to identify Mycobacterium avium subspecies paratuberculosis in livestock populations. The primary catalyst for this growth is the urgent need to address production losses, particularly those resulting from premature culling and diminished milk yields in infected herds. Additionally, strict trade protocols and herd health certification programs mandate frequent surveillance, forcing producers to maintain regular screening schedules. Highlighting the economic stakes, Animal Health Ireland reported in 2024 that the disease costs the Irish dairy industry between €11.24 million and €23.85 million annually, necessitating effective diagnostic solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 675.66 Million
Market Size 2031USD 987.55 Million
CAGR 2026-20316.53%
Fastest Growing SegmentELISA
Largest MarketNorth America

A major obstacle restricting broader market growth is the insufficient sensitivity of existing diagnostic methods during the disease's prolonged subclinical stage. Because infected animals often produce undetectable antibody levels or shed bacteria in low quantities for years, false-negative results are common, which hinders eradication efforts. This technical struggle to detect early-stage infection can erode producer trust in the efficacy of screening, subsequently postponing the widespread implementation of comprehensive testing regimes in cost-conscious livestock operations.

Market Driver

Technological innovations in rapid serological and molecular diagnostics are fundamentally transforming the market by satisfying the urgent requirement for sensitivity and speed in detecting Mycobacterium avium subspecies paratuberculosis. The rise of high-throughput PCR and phage-based technologies now permits the identification of viable bacteria significantly faster than legacy culture methods, which historically took months. For instance, the Animal Health Media Journal reported in November 2024, in an article titled 'New test detects Johne's disease in day-old calves,' that a novel diagnostic system could identify active infection at least four weeks sooner than standard fecal PCR in 75% of trial instances. These advancements are crucial for interrupting transmission chains, allowing farmers to isolate infectious stock before they contaminate the environment and harm production metrics.

Furthermore, the enforcement of Government-Mandated Disease Control and Eradication Programs acts as a secondary major driver, making regular screening a standard operational necessity. These regulatory frameworks frequently tie market access to herd health status, obliging farmers to follow rigorous testing schedules to preserve trade certifications. As noted in 'Changes in the Johne's Disease situation in GB dairy herds over 10 years' in Preventive Veterinary Medicine (August 2024), surveillance data indicated that the top 25% of herds with high average test values were responsible for 42% of all positive results, emphasizing the importance of centralized schemes in managing high-risk reservoirs. Moreover, these programs promote comprehensive management; according to the Journal of Dairy Science in 2024, incorporating young stock into testing protocols could decrease disease transmission by up to 30%, thereby boosting the global demand for diagnostic supplies.

Market Challenge

A significant impediment to the growth of the Global Johne's Disease Diagnostics Market is the inadequate sensitivity of existing tools during the disease's extended subclinical phase. Since infected livestock frequently carry Mycobacterium avium subspecies paratuberculosis for years without generating adequate antibody responses or shedding detectable bacterial loads, standard assays often return false-negative results. This inability to accurately detect early-stage carriers damages producer confidence regarding the cost-efficiency of surveillance initiatives. When significant investments in screening fail to stop subsequent outbreaks because of undetected spreaders, livestock owners often hesitate to commit to the recurring testing schedules that generate market revenue.

This skepticism is further bolstered by data demonstrating low detection rates within managed populations. According to the Action Group on Johne's, the mean prevalence of positive milk ELISA results in monitored herds across the United Kingdom was recorded at 2.7% in 2024. While this figure suggests effective management, it also underscores the challenge diagnostics face in revealing the broader reservoir of subclinical infection, thereby discouraging the widespread implementation of aggressive screening protocols among cost-sensitive farming operations.

Market Trends

The rise of AI-Powered MicroRNA Biomarker Technologies is revolutionizing the Global Johne's Disease Diagnostics Market by resolving the sensitivity limitations inherent in traditional serology. In contrast to ELISA tests, which depend on lagging antibody production, microRNA profiling examines host-response gene expression to detect subclinical carriers before they become infectious. Utilizing machine learning algorithms, this molecular strategy enables the precise classification of early infection stages that standard assays miss. As reported by DVM360 in May 2025, in the article 'New diagnostic approach may help detect Johne disease in cattle earlier,' a newly validated AI-driven microRNA model achieved 71.8% accuracy in detecting Stage I and II infections, providing a vital tool for identifying silent spreaders and breaking transmission cycles.

Simultaneously, the integration of diagnostic testing with cloud-based herd management platforms is moving the industry from reactive diagnosis toward predictive risk stratification. Advanced software solutions now compile historical testing data to produce dynamic risk scores, enabling producers to foresee disease progression rather than simply responding to positive results. This digital shift supports algorithmic clustering to pinpoint high-risk animals that might be overlooked by standard protocols. According to Farmers Weekly in February 2025, in the article 'Johne's risk detection improved with new data analysis tool,' predictive analytics showed that animals within specific high-risk data clusters were up to 1,000 times more likely to advance to an infectious state than low-risk counterparts, facilitating proactive biosecurity measures.

Key Market Players

  • Zoetis Inc.
  • Thermo Fisher Scientific, Inc.
  • PBD Biotech Ltd
  • IDEXX Laboratories, Inc.
  • Innovative Diagnostics SAS
  • VMRD Inc.
  • BIOMeRIEUX S.A.
  • INDICAL BIOSCIENCE GmbH
  • Tetracore, Inc.
  • Surefarm Ltd

Report Scope

In this report, the Global Johne's Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Johne's Disease Diagnostics Market, By Animal Type

  • Cattle
  • Goat
  • Sheep

Johne's Disease Diagnostics Market, By Test Type

  • ELISA
  • PCR
  • AGID
  • Others

Johne's Disease Diagnostics Market, By End User

  • Veterinary Hospitals & Clinics
  • Others

Johne's Disease Diagnostics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Johne's Disease Diagnostics Market.

Available Customizations:

Global Johne's Disease Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Johne's Disease Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal Type (Cattle, Goat, Sheep)
    • 5.2.2. By Test Type (ELISA, PCR, AGID, Others)
    • 5.2.3. By End User (Veterinary Hospitals & Clinics, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Johne's Disease Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal Type
    • 6.2.2. By Test Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Johne's Disease Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.2. By Test Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Johne's Disease Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal Type
        • 6.3.2.2.2. By Test Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Johne's Disease Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal Type
        • 6.3.3.2.2. By Test Type
        • 6.3.3.2.3. By End User

7. Europe Johne's Disease Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal Type
    • 7.2.2. By Test Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Johne's Disease Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal Type
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By End User
    • 7.3.2. France Johne's Disease Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal Type
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Johne's Disease Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal Type
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Johne's Disease Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal Type
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Johne's Disease Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal Type
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By End User

8. Asia Pacific Johne's Disease Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal Type
    • 8.2.2. By Test Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Johne's Disease Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal Type
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Johne's Disease Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal Type
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Johne's Disease Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal Type
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Johne's Disease Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal Type
        • 8.3.4.2.2. By Test Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Johne's Disease Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal Type
        • 8.3.5.2.2. By Test Type
        • 8.3.5.2.3. By End User

9. Middle East & Africa Johne's Disease Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type
    • 9.2.2. By Test Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Johne's Disease Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal Type
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Johne's Disease Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal Type
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Johne's Disease Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal Type
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By End User

10. South America Johne's Disease Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type
    • 10.2.2. By Test Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Johne's Disease Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal Type
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Johne's Disease Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal Type
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Johne's Disease Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal Type
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Johne's Disease Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zoetis Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc.
  • 15.3. PBD Biotech Ltd
  • 15.4. IDEXX Laboratories, Inc.
  • 15.5. Innovative Diagnostics SAS
  • 15.6. VMRD Inc.
  • 15.7. BIOMeRIEUX S.A.
  • 15.8. INDICAL BIOSCIENCE GmbH
  • 15.9. Tetracore, Inc.
  • 15.10. Surefarm Ltd

16. Strategic Recommendations

17. About Us & Disclaimer